Mylan Pharmaceuticals Inc: Mycophenolate Mofetil For Injection Usp, 500 Mg/vial, Single Dose Vial, 4 Vials Per Carton
Recall Summary Mylan Pharmaceuticals is recalling Mycophenolate Mofetil for Injection USP (500 mg vials) distributed nationwide because the medication contains precipitate, or solid particles suspended in the liquid. This is a Class II recall, meaning use of the affected product could cause serious health problems or death. The recalled product was distributed across all U.S. states and Washington, D.C.
- Recalling firm
- MYLAN PHARMACEUTICALS INC
- Product
- Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
- Reason
- Presence of precipitate
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-02
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- USA Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/236a08cb-2774-4319-8261-bad2cb1563c5